A new breakthrough in vaccine technology could change the way we fight cancer, and it may sound familiar. Scientists are now working on mRNA-based vaccines designed not to prevent cancer, but to help treat it after it’s diagnosed. According to a report from Fox 8 News, researchers say the approach could train the body’s immune system to recognize and attack cancer cells more effectively.
If it sounds like the COVID-19 vaccines, that’s because it is, at least in concept. Experts say these would be “therapeutic vaccines,” meaning they’re created after cancer is detected. Doctors could take a sample of a patient’s tumor and design a vaccine that targets the specific proteins unique to that cancer.
In simple terms: your body gets help identifying the enemy and goes after it.
One of the most exciting parts? Speed.
Researchers say mRNA technology allows vaccines to be developed much faster than traditional methods, opening the door to more personalized cancer treatment.
The vaccines are still in early development, but experts say the outlook is encouraging. Some even believe mRNA could eventually be used not just to treat cancer, but to help prevent certain types altogether.
